Your browser doesn't support javascript.
loading
Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients.
Votavova, Hana; Urbanova, Zuzana; Kundrat, David; Dostalova Merkerova, Michaela; Vostry, Martin; Hruba, Monika; Cermak, Jaroslav; Belickova, Monika.
Afiliação
  • Votavova H; Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic.
  • Urbanova Z; First Faculty of Medicine, Charles University, Katerinská 32, 121 08 Prague, Czech Republic.
  • Kundrat D; Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic.
  • Dostalova Merkerova M; Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic.
  • Vostry M; Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic.
  • Hruba M; Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic.
  • Cermak J; Department of Genomics, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic.
  • Belickova M; First Faculty of Medicine, Charles University, Katerinská 32, 121 08 Prague, Czech Republic.
Pharmaceuticals (Basel) ; 14(1)2021 Jan 07.
Article em En | MEDLINE | ID: mdl-33430232
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article